Introduction

Foreword
from Prof. Jie He

Beijing has always been a cancer research hub, which contributed innovative ideas to many hot topics at the research frontier, playing a leading role in international and domestic studies.

Cell Press and the Beijing Municipal Science and Technology Commission have collected 10 representative papers published by Chinese scholars in the Cell Press journals, conducted in-depth interviews with extraordinary scientists in Beijing, and analyzed cancer research development in the area.

Let us continue to strive with faith and courage to work towards a healthy China and contribute to the innovation and development of cancer research worldwide!

The Galaxy Soho Central Beijing
The Temple of Heaven Beijing

Papers

The discoveries that advance the science

The exceptional discoveries in oncology and cancer research made by scientists and clinicians in Beijing are captured by a suite of Cell Press journals, among which we highlight several representatives showcasing the diverse topics and broad scope of these achievements.

Hover over journal covers on the left to learn more about selected papers.


Cancer Cell

VOLUME 33, ISSUE 3, P480-494.E7, 03/12/2018,

Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation

Read more

Cell

VOLUME 175, ISSUE 4, P1059-1073.E21, 11/01/2018,

The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery

Read more

Cell

VOLUME 175, ISSUE 6, P1665-1678.E18, 11/29/2018,

Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor Cell

Read more

Cell Reports

VOLUME 27, ISSUE 6, P1934-1947.E5, 05/07/2019,

Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer

Read more

Cancer Cell

VOLUME 35, ISSUE 6, P932-947.E8, 06/10/2019,

Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes

Read more

Cell Reports

VOLUME 30, ISSUE 6, P1780-1797.E6, 02/11/2020,

Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway

Read more

Cell

VOLUME 181, ISSUE 2, P442-459.E29, 04/16/2020,

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer

Read more

Cell

VOLUME 182, ISSUE 1, P245-261.E17, 07/09/2020,

Integrative Proteomic Characterization of Human Lung Adenocarcinoma

Read more

Cancer Cell

VOLUME 38, ISSUE 4, P551-566.E11, 10/12/2020,

Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies

Read more

Cell Reports

VOLUME 33, ISSUE 3, 108278, 10/20/2020,

PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction

Read more
CCTV Headquarters Beijing Central Business District

Performance

The science that accelerates progress

Celebrating Beijing’s role as a global center of impactful oncology and cancer research. The diagrams below chart the city’s scholarly outputs and activities across this critical medical discipline.


Oncology and cancer research output in Beijing grew 277% from 873 publications in 2010 to 3,287 in 2020


100 institutions in Beijing have publications within the disciplines of oncology and cancer research


Between 2010 and 2018 the NFSC awarded 155 million USD in grants to cancer research in Bejjng